Mike brings nearly three decades of experience to his role as Freenome’s Chief Executive Officer, building on a proven record of delivering transformative diagnostic technologies that help clinicians drive better outcomes for their patients. Previously, Mike served as the company’s Chief Business Officer, where he led Freenome’s corporate and business development, product management, clinical development and operations, program management, and marketing teams. He also oversaw partnerships with biopharma companies, academic medical centers, and health systems where our multiomics platform is deployed to move research and medicine forward.
Mike came to Freenome from Foundation Medicine, where he served as SVP of Commercial Operations and led a cross-functional team to expand the use of next-generation sequencing technologies in cancer.
Prior, Mike held global general management and commercial leadership roles for many industry leaders, including Thermo Fisher, Luminex, Roche Molecular Systems, Roche Diagnostics, and Abbott Diagnostics.
Mike holds a B.S. in Biological Sciences and Secondary Education, along with an MBA from the University of Wyoming.